Olimel N7e (Valine, Alanine, Arginine, Histidine, Isoleucine, Leucine, Methionine, Phenylalanine, Proline, Serin)

Olimel N7e provides amino acid supplementation that supports several clinical nutrition pathways.

• Protein‑energy malnutrition: helps restore nitrogen balance and lean body mass.
• Post‑operative recovery: contributes to wound healing and tissue repair.
• Chronic kidney disease (conservative management): assists in maintaining essential amino acid levels when dietary intake is restricted.
• Severe burns or trauma: supports increased protein turnover and metabolic demand.
• Long‑term parenteral nutrition: complements amino acid mixtures used in intravenous feeding protocols.

• The amino acids in Olimel N7e are absorbed through the gastrointestinal tract and enter the systemic circulation, where they serve as substrates for protein synthesis, act as precursors for neurotransmitters and metabolic intermediates, and participate in nitrogen transport. By replenishing essential and conditionally essential amino acids, the formulation helps maintain cellular function and supports anabolic processes during catabolic stress.

Adverse reactions to amino‑acid mixtures are generally mild and related to gastrointestinal tolerance.

Common Side Effects

• Nausea: mild to moderate upset stomach.
• Diarrhea: loose stools, especially with rapid dose escalation.
• Abdominal discomfort: cramping or bloating.
• Metallic taste: transient alteration in mouthfeel.
• Headache: occasional mild headache.
• Skin redness at oral mucosa: mild irritation.

Serious or Rare Side Effects

• Allergic reaction: rash, itching, swelling, or anaphylaxis.
• Hyperammonemia: elevated blood ammonia in patients with severe liver dysfunction.
• Metabolic acidosis: rare disturbance of acid‑base balance.
• Severe electrolyte imbalance: especially if combined with high‑dose mineral supplements.
• Renal impairment exacerbation: in patients with pre‑existing kidney disease when protein load is excessive.
• Unexplained fever: persistent temperature rise without infection.

When prescribing Olimel N7e, clinicians should consider patient‑specific factors and monitor relevant parameters.

• Assess nutritional status: evaluate baseline protein and amino‑acid levels before initiating therapy.
• Monitor renal function: adjust dosage in patients with impaired kidney clearance.
• Watch for hepatic dysfunction: avoid excessive dosing in severe liver disease.
• Observe for allergic history: discontinue if hypersensitivity develops.
• Evaluate concomitant medications: consider potential additive nitrogen load.
• Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Amino‑acid supplements can interact with certain drugs, altering absorption or metabolic pathways.

Major Interactions (Avoid)

• Levodopa: competition for transport may reduce central availability.
• MAO inhibitors: increased risk of hypertensive crisis with tyramine‑rich amino‑acid blends.
• High‑dose mineral supplements (e.g., calcium, iron): may impair amino‑acid absorption.

Moderate Interactions (Monitor Closely)

• Anticonvulsants (e.g., valproate): may affect plasma amino‑acid concentrations.
• Diuretics: can increase renal loss of amino acids.
• Antibiotics (e.g., tetracycline): reduced absorption when taken concurrently.